CLB — Core Laboratories Share Price
0.000.00%
Last trade - 00:00- $805.13m
- $958.14m
- $509.79m
- 98
- 32
- 40
- 57
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 17.62 | ||
| PEG Ratio (f) | 1.25 | ||
| EPS Growth (f) | 16.35% | ||
| Dividend Yield (f) | 0.23% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.58 | ||
| Price to Tang. Book | 6.8 | ||
| Price to Free Cashflow | 56.66 | ||
| Price to Sales | 1.58 | ||
| EV to EBITDA | 13.57 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 10.97% | ||
| Return on Equity | 17.93% | ||
| Operating Margin | 10.72% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 668.21 | 487.27 | 470.25 | 489.74 | 509.79 | 528.61 | 577.62 | -6.17% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +16.94 | n/a | n/a | +10.37 | +83.29 | +7.34 | +35.57 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Core Laboratories Inc. is a provider of proprietary and patented reservoir description and production enhancement services and products for the oil and gas industry. The Company helps to evaluate and improve reservoir performance and increase oil and gas recovery from new and existing fields. It makes measurements of reservoir rocks, reservoir fluids (crude oil, natural gas and water) and their derived products. In addition, the Company assists clients in evaluating subsurface targets associated with carbon capture and sequestration projects or initiatives. The Company has two segments. Reservoir Description segment provides laboratory-based analytical and field services to characterize the properties of crude oil and crude oil-derived products for the oil and gas industry. In addition, it provides reservoir description capabilities. Production Enhancement segment provides integrated diagnostic services. The Company has approximately 70 offices in more than 50 countries.
Directors
- Lawrence Bruno CSU (61)
- Christopher Hill CFO (51)
- Mark Elvig GCN
- Martha Carnes LED (61)
- Gregory Barnett IND (59)
- Harvey Klingensmith IND (68)
- Michael Straughen IND (71)
- Monique Van Dijken Eeuwijk IND (51)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- May 1st, 2023
- Public Since
- October 22nd, 2018
- No. of Shareholders
- 195
- No. of Employees
- 3,600
- Sector
- Professional & Commercial Services
- Industry
- Industrials
- Exchange
- New York Stock Exchange
- Shares in Issue
- 46,864,366
- Address
- 6316 Windfern Road, HOUSTON, 77040
- Web
- https://www.corelab.com/
- Phone
- +1 7133282673
- Auditors
- KPMG LLP
Upcoming Events for CLB
Q1 2024 Core Laboratories Inc Earnings Call
Core Laboratories Inc Annual Shareholders Meeting
Similar to CLB
ABM Industries
New York Stock Exchange
ACCO Brands
New York Stock Exchange
AerCap Holdings NV
New York Stock Exchange
Air Lease
New York Stock Exchange
ARC Document Solutions
New York Stock Exchange
FAQ
What is the Core Laboratories share price?
As of Today at 19:06 UTC, shares in Core Laboratories are trading at $17.18. This share price information is delayed by 15 minutes.
How has the Core Laboratories share price performed this year?
Shares in Core Laboratories last closed at $17.18 and the price had moved by -20.17% over the past 365 days. In terms of relative price strength the Core Laboratories share price has underperformed the S&P500 Index by -33.57% over the past year.
What are the analyst and broker recommendations for Core Laboratories?
The overall consensus recommendation for Core Laboratories is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the Core Laboratories dividend yield?
The Core Laboratories dividend yield is 0.23% based on the trailing twelve month period.
Does Core Laboratories pay a dividend?
Last year, Core Laboratories paid a total dividend of $0.04, and it currently has a trailing dividend yield of 0.23%. We do not have any data on when Core Laboratories is to next pay dividends.
When does Core Laboratories next pay dividends?
We do not have data on when Core Laboratories is to next pay dividends. The historic dividend yield on Core Laboratories shares is currently 0.23%.
How do I buy Core Laboratories shares?
To buy shares in Core Laboratories you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Core Laboratories?
As of the previous close price of $17.18, shares in Core Laboratories had a market capitalisation of $805.13m.
Where are Core Laboratories shares listed?
Here are the trading details for Core Laboratories:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: CLB
What kind of share is Core Laboratories?
Based on an overall assessment of its quality, value and momentum Core Laboratories is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Core Laboratories share price forecast for 2024?
The analyst consensus target price for shares in Core Laboratories is $19.38. That is 12.81% above the last closing price of $17.18.
Analysts covering Core Laboratories currently have a consensus Earnings Per Share (EPS) forecast of $0.88 for the next financial year.
What is the trend in the Core Laboratories share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Core Laboratories. Over the past six months, its share price has underperformed the S&P500 Index by -37.02%.
As of the last closing price of $17.18, shares in Core Laboratories were trading -13.89% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Core Laboratories PE Ratio?
The Core Laboratories PE ratio based on its reported earnings over the past 12 months is 17.62. The shares last closed at $17.18.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Core Laboratories?
Core Laboratories' management team is headed by:
- Lawrence Bruno - CSU
- Christopher Hill - CFO
- Mark Elvig - GCN
- Martha Carnes - LED
- Gregory Barnett - IND
- Harvey Klingensmith - IND
- Michael Straughen - IND
- Monique Van Dijken Eeuwijk - IND